Fundz

Adaptyv has secured €34.35 million in Series A funding to scale its lab operations and expand research capabilities, led by Highland Europe with support from existing investors.

PRIVATEAug 28, 2026

Amount Raised

€34.4 Million

Round Type

Series A

VaudBiotechnologyArtificial Intelligence

Investors

ByfoundersHighland EuropeY CombinatorAce Ventures

Description

Lausanne-based Adaptyv, a biotech startup, has raised €34.35 million in Series A funding. The funding will be used to enhance lab capacity, including opening a new facility in London and expanding its operations in Lausanne. The round was led by Highland Europe, with participation from Ace Ventures, ByFounders, and Y Combinator. Adaptyv specializes in automated protein design, leveraging AI to bridge the gap between digital design and physical validation.

Quick answer

Adaptyv Biosystems raised €34.4 Million in a Series A round, dated August 28, 2026. Investors: Byfounders, Highland Europe, Y Combinator and Ace Ventures. Adaptyv Biosystems is based in Vaud, Switzerland.

How much did Adaptyv Biosystems raise?
Adaptyv Biosystems raised €34.4 Million in a Series A round on August 28, 2026.
Who invested in Adaptyv Biosystems?
Byfounders, Highland Europe, Y Combinator and Ace Ventures are named as investors in this round.
What does Adaptyv Biosystems do?
Adaptyv Biosystems is a biotech start-up based in Épalinges that focuses on automating the experimental validation of AI-generated protein designs.
Where is Adaptyv Biosystems based and how big is it?
Adaptyv Biosystems is based in Vaud, Switzerland.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Adaptyv Biosystems that raised within 45 days of this round, from Fundz verified event records.

  • Scarlet raised $50M (Series B) on October 12, 2026.
  • Matter Machine raised $5.3M (Pre-Series A) on October 11, 2026.
  • Wavena raised $150K (Seed) on October 8, 2026.
  • Peppermint raised $4.7M (Seed) on October 8, 2026.
  • Quanfluence raised $10M (Series A) on October 7, 2026.
  • Rivercell raised $25M (Seed) on October 7, 2026.

Who to call at Adaptyv Biosystems, and when

A new round usually means Adaptyv Biosystems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adaptyv Biosystems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adaptyv Biosystems, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adaptyv Biosystems. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adaptyv Biosystems

Location

Vaud, Switzerland

About

Adaptyv Biosystems is a biotech start-up based in Épalinges that focuses on automating the experimental validation of AI-generated protein designs. Their cloud-based laboratory enables researchers to conduct real-world validation tests while streamlining the design-test-learn cycle. Adaptyv has successfully collaborated with over 30 pharma, biotech, and AI research partners, demonstrating significant improvements in protein success rates. The company aims to enhance automation and make experimental validation more scalable.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adaptyv Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Adaptyv Biosystems's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Adaptyv Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.